PubMed Health⌕ Search

PubMed · 2359515

Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d.

Abstract

Clusters of oligodendroglial fibers were identified immunohistochemically in human brain tissue with antibodies to the complement proteins C3d and C4d in several neurological disorders. These included Pick's, Huntington's, Parkinson's and Alzheimer's disease, amyotrophic lateral sclerosis, progressive supranuclear palsy and Shy-Drager syndrome. These complement-activated oligodendroglia occurred in selected areas of gray and white matter. They were rarely observed in control tissue. Immunogold electron microscopy established that the C4d antibody was attached to degenerating myelin sheaths. These data indicate attachment of classical complement pathway proteins to selective oligodendroglia in several neurological disorders.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Yamada, H Akiyama, P L McGeer. 1990-05-04. Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d.. https://doi.org/10.1016/0304-3940(90)90196-g

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A penalized likelihood approach to magnetic resonance image reconstruction.

Currently, images acquired via magnetic resonance imaging (MRI) and functional magnetic resonance imaging (fMRI) technology are reconstructed using the discrete inverse Fourier transform. While computationally convenient, this approach is not able to filter out noise. This is a serious limitation because the amount of noise in MRI and fMRI can be substantial. In this paper, we propose an alternative approach to reconstruction, based on penalized likelihood methodology. In particular, we focus on non-linear shrinkage estimators and show that this approach achieves a great reduction in integrated mean squared error (IMSE) of the estimated image with respect to the currently used estimator. This approach is extremely fast and easy to implement computationally. In addition, it can be combined with various alternative approaches to MR image reconstruction and can be easily adapted to other, non-MRI contexts, in which the observed data and the quantities of interest are related via a linear transform.

Brain Diseases↗